Study Could Provide Breast Cancer Breakthrough

Study Could Provide Breast Cancer Breakthrough

The drug combination has not been approved to be used in the early stages of HER2 positive breast cancer patients in the U.S. However, Dr. Reddy said treatment with Herceptin alone returns really good results. But he expects the U.S. to be on-board

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.